Frankfurt - Delayed Quote EUR

IRLAB Therapeutics AB (6IRA.F)

0.6460
-0.0100
(-1.52%)
As of 8:14:40 AM GMT+2. Market Open.
Loading Chart for 6IRA.F
  • Previous Close 0.6560
  • Open 0.6460
  • Bid 0.6960 x --
  • Ask 0.7200 x --
  • Day's Range 0.6460 - 0.6460
  • 52 Week Range 0.3560 - 1.4600
  • Volume 3,200
  • Avg. Volume 55
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jul 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 6IRA.F

View More

Performance Overview: 6IRA.F

Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

6IRA.F
30.24%
OMX Stockholm 30 Index (^OMX)
1.81%

1-Year Return

6IRA.F
50.69%
OMX Stockholm 30 Index (^OMX)
3.69%

3-Year Return

6IRA.F
79.75%
OMX Stockholm 30 Index (^OMX)
25.69%

5-Year Return

6IRA.F
84.64%
OMX Stockholm 30 Index (^OMX)
66.03%

Compare To: 6IRA.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6IRA.F

View More

Valuation Measures

As of 5/12/2025
  • Market Cap

    34.11M

  • Enterprise Value

    32.09M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.75

  • Price/Book (mrq)

    80.19

  • Enterprise Value/Revenue

    3.54

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 6IRA.F

View More